Weekly: Halozyme Therapeutics (HALO: $39.93) shares post best week in seventeen weeks; +$2.68 [7.2%]

Press/Media

PeriodNov 18 2023

Media coverage

1

Media coverage

  • TitleWeekly: Halozyme Therapeutics (HALO: $39.93) shares post best week in seventeen weeks; +$2.68 [7.2%]
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date11/18/23
    PersonsMary Daly
View all 1
View less